[1] |
Prokofyeva E, Zrenner E. Epidemiology of Major Eye Diseases Leading to Blindness in Europe: A Literature Review[J]. Ophthalmic Research, 2011, 47(4):171-188.
|
[2] |
Yang K, Liang YB, Gao LQ, et al. Prevalence of Age-Related Macular Degeneration in a Rural Chinese Population: The Handan Eye Study[J]. Ophthalmology, 2011, 118(7):1395-1401.
|
[3] |
World Health Organization and Tufts University. School of Nutrition and Policy[C]. Geneva: Switzerland, 2002.
|
[4] |
Pai MK. Comparative study of nutritional status of elderly population living in the home for aged vs those living in the community[J]. Biomedical Research, 2011, 22(1):120-126.
|
[5] |
Chakravarthy U, Wong TY, Fletcher A, et al. Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis[J]. BMC Ophthalmology, 2010, 10(1):31.
|
[6] |
Fisher DE, Jonasson F, Eiriksdottir G, et al. Age-related macular degeneration and mortality in community-dwelling elders: the age, gene/environment susceptibility Reykjavik study[J]. Ophthalmology, 2015, 122(2):382-390.
|
[7] |
葛坚. 眼科学[M]. 2版. 北京:人民卫生出版社,2013:314.
|
[8] |
Cheung CM, Tai ES, Kawasaki R, et al. Prevalence of and risk factors for age-related macular degeneration in a multiethnic Asian cohort[J]. Arch Ophthalmol, 2012, 130(4):480-486.
|
[9] |
Klein R, Cruickshanks KJ, Nash SD, et al. The prevalence of age-related macular degeneration and associated risk factors[J]. Arch Ophthalmol, 2010, 128(6):750-758.
|
[10] |
Foran S, Mitchell P, Wang JJ. Five-year change in visual acuity and incidence of visual impairment: the Blue Mountains Eye Study[J]. Ophthalmology, 2003, 110(1):41-50.
|
[11] |
Yasuda M, Kiyohara Y, Hata Y, et al. Nine-year incidence and risk factors for age-related macular degeneration in a defined Japanese population the Hisayama study.[J]. Ophthalmology, 2009, 116(11):2135-2140.
|
[12] |
Mitchell P, Wang JJ, Foran S, et al. Five-year incidence of age-related maculopathy lesions: the Blue Mountains Eye Study[J]. Ophthalmology, 2002, 109(6):1092-1097.
|
[13] |
Oshima Y, Ishibashi T, Murata T, et al. Prevalence of age related maculopathy in a representative Japanese population: the Hisayama study[J]. Br J Ophthalmol, 2001, 85(10):1153-1157.
|
[14] |
邹海东,张晳,许迅,等. 上海市静安区曹家渡街道年龄相关性黄斑变性的患病率调查[J]. 中华眼科杂志,2005,41(1):15-19.
|
[15] |
田蔓男,张月梅,李丽,等. 老年性黄斑变性的流行病学调查[J]. 兰州大学学报(医学版),2005,31(2):70-71.
|
[16] |
Clemons TE, Milton RC, Klein R, et al. Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19[J]. Ophthalmology, 2005, 112(4):533-539.
|
[17] |
Jager RD, Mieler WF, Miller JW. Age-related macular degeneration[J]. N Engl J Med, 2008, 358(24):2606-2617.
|
[18] |
Kawasaki R, Yasuda M, Song SJ, et al. The prevalence of age-related macular degeneration in Asians: a systematic review and meta-analysis[J]. Ophthalmology, 2010, 117(5):921-927.
|
[19] |
Sang JP, Kwon KE, Choi NK, et al. Prevalence and Incidence of Exudative Age-Related Macular Degeneration in South Korea: A Nationwide Population-Based Study[J]. Ophthalmology, 2015, 122(10):2063-2070.
|
[20] |
Fraserbell S, Wu J, Klein R, et al. Smoking, alcohol intake, estrogen use, and age-related macular degeneration in Latinos: the Los Angeles Latino Eye Study[J]. Am J Ophthalmol, 2006, 141(1):79-87.
|
[21] |
Sang JP, Ju HL, Woo SJ, et al. Age-Related Macular Degeneration: Prevalence and Risk Factors from Korean National Health and Nutrition Examination Survey, 2008 through 2011[J]. Ophthalmology, 2014, 121(9):1756-1765.
|
[22] |
侯慧媛,王雨生. 吸烟与年龄相关性黄斑变性[J]. 国际眼科纵览,2007, 31(5):330-333.
|
[23] |
Seddon JM, George S, Rosner B. Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration: the US Twin Study of Age-Related Macular Degeneration[J]. Digest of the World Core Medical Journals, 2006, 124(7):995-1001.
|
[24] |
Tan JS, Mitchell P, Smith W, et al. Cardiovascular risk factors and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study[J]. Ophthalmology, 2007, 114(6):1143-1150.
|
[25] |
Bhatiwada N, Sheshappa MB, Prabhu P, et al. Dietary and lifestyle risk factors associated with age-related macular degeneration: A hospital based study[J]. Indian Journal of Ophthalmology, 2013, 61(12):722-727.
|
[26] |
Sui GY, Liu GC, Liu GY, et al. Is sunlight exposure a risk factor for age-related macular degeneration? A systematic review and meta-analysis[J]. Br J Ophthalmol, 2013, 97(4):389-394.
|
[27] |
Youn HY, Mccanna DJ, Sivak JG, et al. In vitro ultraviolet-induced damage in human corneal, lens, and retinal pigment epithelial cells[J]. Molecular Vision, 2011, 17(28):237-246.
|
[28] |
Sheng H, Lu Y, Fengling QL. Effects of Light Exposure and Use of Intraocular Lens on Retinal Pigment Epithelial Cells In Vitro[J]. Photochemistry & Photobiology, 2009, 85(4):966-969.
|
[29] |
Lim LS, Mitchell P, Seddon JM, et al. Age-related macular degeneration[J]. Lancet, 2012, 379(9827):1728-1738.
|
[30] |
Kolár P. Epidemiology of the age-related macular degeneration[J]. Ceská A Slovenská Oftalmologie, 2010, 66(3):127-130.
|
[31] |
Tomany SC, Cruickshanks KJ, Klein R, et al. Sunlight and the 10-year incidence of age-related maculopathy: the Beaver Dam Eye Study.[J]. Archives of Ophthalmology, 2004, 122(5):750-757.
|
[32] |
范瑞,潘星月,杨红梅,等. 老年黄斑变性患者影响因素对照调查分析[J]. 中国实用眼科杂志,2009, 27(9):1048-1050.
|
[33] |
Mares JA, Moeller SM. Diet and age-related macular degeneration: expanding our view[J]. American Journal of Clinical Nutrition, 2006, 83(4):733-734.
|
[34] |
Sangiovanni JP, Chew EY, Agrón E, et al. The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration: AREDS report no. 23[J]. Arch Ophthalmol, 2008, 126(9):1274-1279.
|
[35] |
BialekSzymańska A, MisiukHojo M, Witkowska K. Risk factors evaluation in age-related macular degeneration[J]. Klinika Oczna, 2007, 109(4):127-130.
|
[36] |
Seddon JM, Cote J, Rosner B. Progression of age-related macular degeneration: association with dietary fat, transunsaturated fat, nuts, and fish intake[J]. Arch Ophthalmol, 2003, 121(12):1728-1737.
|
[37] |
Tomany SC, Klein R, Klein BE. The relationship between iris color, hair color, and skin sun sensitivity and the 10-year incidence of age-related maculopathy: the Beaver Dam Eye Study[J]. Ophthalmology, 2003, 110(8):1526-1533.
|
[38] |
Rosen ES. Age-related macular degeneration and cataract surgery[J]. J Cataract Refract Surg, 2014, 40(2):173-174.
|
[39] |
Ula F, Balbaba M, Özmen S, et al. Association of dehydroepiandrosterone sulfate, serum lipids, C-reactive protein and body mass index with age-related macular degeneration[J]. International Ophthalmology, 2013, 33(5):485-491.
|
[40] |
Ikram MK, Van LR, Vingerling JR, et al. Relationship between refraction and prevalent as well as incident age-related maculopathy: the Rotterdam Study[J]. Invest Ophthalmol Vis Sci, 2003, 44(9):3778-3782.
|
[41] |
Choi JK, Lym YL, Moon JW, et al. Diabetes Mellitus and Early Age-related Macular Degeneration[J]. Arch Ophthalmol, 2011, 129(2):196-199.
|
[42] |
Chen X, Rong SS, Xu Q, et al. Diabetes mellitus and risk of age-related macular degeneration: a systematic review and meta-analysis[J]. PloS One, 2014, 9(9):e108196.
|
[43] |
Woo SJ, Ahn J, Morrison MA, et al. Analysis of Genetic and Environmental Risk Factors and Their Interactions in Korean Patients with Age-Related Macular Degeneration[J]. PloS One, 2015, 10(7):e0132771.
|
[44] |
Erke MG, Bertelsen G, Peto T, et al. Prevalence of age-related macular degeneration in elderly Caucasians: the Tromsø Eye Study[J]. Ophthalmology, 2012, 119(9):1737-1743.
|
[45] |
Seddon JM, Cote J, Davis N, et al. Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio[J]. Arch Ophthalmol, 2003, 121(6):785-792.
|
[46] |
Sun Y, Yu W, Huang L, et al. Is asthma related to choroidal neovascularization?[J]. PloS One, 2012, 7(5):e35415.
|
[47] |
Kahawita SK, Casson RJ. Aspirin use and early age-related macular degeneration: a meta-analysis[J]. Canadian Journal of Ophthalmology Journal Canadien Dophtalmologie, 2014, 49(1):35-39.
|
[48] |
Meyers SM. A twin study on age-related macular degeneration[J]. Transactions of the American Ophthalmological Society, 1994, 92(2):775-843.
|
[49] |
Seddon JM, Gensler G, Milton RC, et al. Association between C-reactive protein and age-related macular degeneration[J]. Jama, 2004, 137(5):704-710.
|
[50] |
Klaver CC, Kliffen M, van Duijn CM, et al. Genetic association of apolipoprotein E with age-related macular degeneration[J]. American Journal of Human Genetics, 1998, 63(1):200-206.
|
[51] |
Vingerling JR, Dielemans I, Bots ML, et al. Age-related Macular Degeneration Is Associated with Atherosclerosis: The Rotterdam Study[J]. American Journal of Epidemiology, 1995, 142(4):404-409.
|
[52] |
Boekhoorn SS, Isaacs A, Uitterlinden AG, et al. Polymorphisms in the vascular endothelial growth factor gene and risk of age-related macular degeneration: the Rotterdam Study[J]. Ophthalmology, 2008, 115(11):1899-1903.
|
[53] |
Katta S, Kaur I, Chakrabarti S. The molecular genetic basis of age-related macular degeneration: an overview[J]. Journal of Genetics, 2010, 88(4):425-449.
|
[54] |
Chen Y, Zeng J, Zhao C, et al. Assessing Susceptibility to Age-Related Macular Degeneration With Genetic Markers and Environmental Factors[J]. Arch Ophthalmol, 2011, 129(3):344-351.
|
[55] |
Havvas I, Marioli DI, Deli A, et al. Complement C3, C2, and factor B gene polymorphisms and age-related macular degeneration in a Greek cohort study[J]. European Journal of Ophthalmology, 2014, 24(5):751-760.
|
[56] |
Contreras AV, Zenteno JC, Rodríguezcorona U, et al. CFH haplotypes and ARMS2, C2, C3, and CFB alleles show association with susceptibility to age-related macular degeneration in Mexicans[J]. Molecular Vision, 2014, 20(1):105-116.
|
[57] |
Restrepo NA, Spencer KL, Goodloe R, et al. Genetic determinants of age-related macular degeneration in diverse populations from the PAGE study[J]. Invest Ophthalmol Vis Sci, 2014, 55(10):6839-6850.
|
[58] |
Yu Y, Bhangale TR, Fagerness J, et al. Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration[J]. Human Molecular Genetics, 2011, 20(18):3699-3709.
|
[59] |
Murad N, Kokkinaki M, Gunawardena N, et al. miR-184 regulates ezrin, LAMP-1 expression, affects phagocytosis in human retinal pigment epithelium and is downregulated in age-related macular degeneration[J]. Febs Journal, 2015, 281(23):5251-5264.
|
[60] |
Klein R, Klein BEK, Tomany SC, et al. Ten-Year Incidence of Age-related Maculopathy and Smoking and Drinking: The Beaver Dam Eye Study[J]. Am J Epidemiol, 2002, 156(7):589-598.
|
[61] |
Algvere PV, Seregard S. Drusen maculopathy: a risk factor for AMD. Can we prevent visual loss?[J]. Acta Ophthalmologica Scandinavica, 2003, 81(5):427-429.
|
[62] |
Wu KH, Madigan MCBillson FA, Penfold PL. Differential expression of GFAP in early v late AMD: a quantitative analysis[J]. Br J Ophthalmol, 2003, 87(9):1159-1166.
|
[63] |
Nilsson UL, Frennesson CNilsson SE. Patients with AMD and a large absolute central scotoma can be trained successfully to use eccentric viewing, as demonstrated in a scanning laser ophthalmoscope[J]. Vision Research, 2003, 43(16):1777-1787.
|
[64] |
Miller DW, Joussen AM, Holz FG. Die molekularen Mechanismender neovaskularen AMD[J]. Der Ophthalmologe, 2003, 100(2):92-96.
|
[65] |
Eter N, Vogel A, Inhetvin-Hutter C, et al. Interval reduction of photodynamic therapy (PDT) in age-related macular degeneration (AMD) is not advantageous. A pilot project[J]. Der Ophthalmologe, 2003, 100(4):314-317.
|